期刊文献+

激发型4-1BBL单抗在体内对人白血病系胞系SHI-1生物学行为的影响

Effects of the monoclonal antibody against the provocative type of human 4-1BB on the biological characteristics of the monocytic leukemia cell line SHI-1
下载PDF
导出
摘要 通过激发型4-1BBL单抗作用于人M5型白血病-SCID小鼠模型,研究4-1BBL/4-1BB逆向信号在体内对M5型白血病细胞系SHI-1生物学行为的影响。将1×106SHI-1细胞移植至SCID小鼠腹腔,经1F1单抗作用,于移植30 d后小鼠尾静脉取血并采用流式细胞术(FCM)监测4-1BBL阳性细胞表达率。于移植42 d后处死小鼠,通过病理组织学检查和FCM,分析SCID小鼠的骨髓、外周血、肝脏和脾脏中白血病细胞的浸润及病理变化。结果:各组小鼠腹腔均可发现瘤块生长。单抗作用组小鼠肿块出现较早,生长速度较快,其主要组织器官更发现有肿瘤细胞的浸润。1F1单抗在体内可促进SHI-1细胞的增殖与迁移,这为研究M5型白血病的发生与发展提供了理论依据。 To investigate the effects and mechanism of the 4-1BB reverse signaling on the monocytic leukemia cell line SHI-1 of severe combined immunodeficiency(SCID) mice, the SHI-1/SCID mouse model was established by interperitoneal injection with 1 × 10^6 SHI-1 cells into SCID mice. Seven days after transplantation, the 1F1 monoclonal antibody prepared in our laboratory was injected into mice intra-peritoneally, and serial tail vein blood samples at regular intervals were taken to detect the expression of 4-IBB ligand(4-IBBL) on SWHI-1 cells by flow cytometry(FCM). Forty two days after transplantation, all the experimental mice were killed and the infiltration with leukemia cells as well as the pathologic changes in bone marrow, peripheral blood, liver and spleen of SCID mice were analyzed by means of immunohistochemical examinations and FCM assay. It was found that growth of tumor masses in peritoneal cavity could be demonstrated in various groups of experiments in mice, in which the growth of tumor masses appeared early and fast in case of mice treated with monoclonal antibody than that of the contro.1 mice, and infiltration with tumor cells could be found on the chief organs. It is concluded that 4-IBBL reverse signaling can promote the proliferation and migration of SHI-1 cells in vivo. This result may be significant for the biological study and treatment of acute monocytic leukemia.
出处 《现代免疫学》 CAS CSCD 北大核心 2007年第6期449-452,共4页 Current Immunology
基金 国家自然科学基金青年科学基金资助项目(30400394) 江苏省135工程基金资助项目(2003-2006年)
关键词 4-1BBL 白血病 急性 SCID小鼠 4-IBBL leukemia SCID
  • 相关文献

参考文献11

  • 1Alderson MR, Smith CA, Tough TW, et al. Molecular and biological characterization of human 4-1BB and its ligand[J]. Eur J Immunol, 1994,24:2219.
  • 2DeBenedette MA, Chu NR, Pollok KE, et al. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its up-regulation on M12 B lymphoma by camp[J]. J Exp Med, 1995,181:985-992.
  • 3DeBenedette MA, Shahinian A, Mak TW, et al. Costimulation of CD28^- T lymphocytes by 4-1BB ligand[J]. J Immunol, 1997,158:551-559.
  • 4Micbae L. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity[J]. Nat Rev, 2003,3 : 600-620.
  • 5Salih HR, Schmetzer HM, Burke C, et al. Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies [J]. J Immunol, 2001,167(7) :4059-4066.
  • 6张烽,马倩茹,席泓,周桓,张学光,顾宗江.小鼠髓系树突状细胞4-1BB及4-1BBL表达调节[J].现代免疫学,2006,26(3):183-186. 被引量:2
  • 7Palma C, Binasehi M, Bigioni M, et al. CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival[J]. Int J Cancer, 2004, 20;108(3) :390-398.
  • 8Ju SW, Ju SG, Wang FM, et al. A functional anti-human 4-1BB ligand monoclonal antibody that enhances proliferation of monocytes by reverse signaling of 4-1BBL[J]. Hybrid Hybridomics, 2003,22(5) :333-341.
  • 9陈苏宁,薛永权,张学光,吴亚芳,潘金兰,王勇,岑建农.一株伴有t(6;11)(q27;q23)和p53基因异常的人单核细胞白血病细胞系SHI-1的建立及鉴定[J].中华血液学杂志,2005,26(2):94-99. 被引量:17
  • 10Salih H, Kosowski S, Haluska V, et al. Constitutive expression of functional 4-1BB(CD137) ligand on carcinoma cells[J]. J Immunol, 2000,165 : 2903-2910.

二级参考文献22

  • 1陈苏宁,薛永权,张学光,吴亚芳,潘金兰,王勇,岑建农.一株伴有t(6;11)(q27;q23)和p53基因异常的人单核细胞白血病细胞系SHI-1的建立及鉴定[J].中华血液学杂志,2005,26(2):94-99. 被引量:17
  • 2李敏,陈成,张烽,古涛,朱一蓓,於葛华,马泓冰,戴俊,张学光,顾宗江.小鼠髓系树突状细胞上4-1BB分子的功能性表达[J].苏州大学学报(医学版),2004,24(6):791-793. 被引量:2
  • 3薛永权 过宇.介绍一种改良的骨髓细胞染色体热变性姬姆萨R显带法[J].中华医学检验杂志,1986,9:247-247.
  • 4Drexler HG, Matsuo Y, Macleod RAF. Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research. Leuk Res,2000, 24:881-911.
  • 5Mitterbauer G, Zimmer C, Fonatseh C, et al. Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukemia by RT-PCR. Leukemia, 1999,13:1519-1524.
  • 6Nollet F, Billiet J, Selleslag D, et al. Standardization of multiplex fluorescent short tandem repeat analysis for chimerism testing. Born, Marros Transplant,2001 ,28:511-518.
  • 7Drexler HG, F6mbonne S, Matsuo Y, et al. p53 alterations in human leukemia-lymphoma cell lines: in vitroariifaet or prerequisite for cell immortalization? Leukemia,2000, 14 : 198-206.
  • 8Uphoff CC, Drexler HG. Detection of mycoplasma in leukemialymphoma cell lines using pnlymerase chain reaction. Leukemia, 2002,16: 289-293.
  • 9Drexler HG,Dirks WG, Matsuo Y, et al. False letzkemia-lymphoma cell lines: an update on over 500 cell lines, Leukemia,2003, 17:416-426.
  • 10Drexler HG, Matsuo Y. Guidelines for the charaetelization and publieatinn of human malignant hematupoietie cell lines. Leukemia,1999, 13:835-842.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部